Wyeth Pharmaceuticals

Huntercombe Lane South, Taplow, Maidenhead, Berks, SL6 0PH
Telephone: +44 (0)1628 604 377
Fax: +44 (0)1628 666 368
Medical Information Direct Line: +44 (0)845 367 0098
Medical Information e-mail: ukmedinfo@wyeth.com
Medical Information Fax: +44 (0)845 367 0777
Summary of Product Characteristics last updated on the eMC: 01/07/2009
SPC ReFacto AF

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 01/07/2009 and displayed until Current
Reasons for adding or updating:
  • Change to section 9 - Date of first Authorisation/renewal of the Authorisation
Date of revision of text on the SPC:   15-Apr-2009
Legal Category:   POM
Black Triangle (CHM):   YES

Free-text change information supplied by the pharmaceutical company

Section 9: Change to format of text.  No actual change to text.
Updated on 01/06/2009 and displayed until 01/07/2009
Reasons for adding or updating:
  • New SPC for new product
Date of revision of text on the SPC:  
Legal Category:   POM
Black Triangle (CHM):   YES

Free-text change information supplied by the pharmaceutical company

None provided

Active Ingredients/Generics

 
   moroctocog alfa


© 2009 Datapharm Communications Ltd

Go to www.medicines.org.uk